Abstract:ID 87806 Poster Board 496 Benzodiazepines (BZs) are safe and effective therapeutics for anxiety when used as directed, however, BZs have unwanted side effects like potential for misuse, physical dependence, and toxicity when combined with other substances. BZs bind to a site on the GABA A receptor located at the interface of the alpha and gamma subunit, with alpha 1, alpha 2, and alpha 3 subunit-containing receptors likely involved in their reinforcing effects. Furthermore, compounds that lack efficacy at the alpha 1 subunit-containing GABA A receptor (alpha 1 sparing compounds) appear to have reduced addiction potential, though their reinforcing effects are dependent upon past drug experience. Choice procedures were used to evaluate whether subjects without prior drug experience would self-administer alpha 1 sparing compounds when substituted for food or when combined with food. Two female and two male rhesus monkeys chose between a fixed food amount on one option (1 or 2 pellets/delivery) and on the other option, in different conditions, between increasing food amounts (0-4 pellets/delivery), increasing drug doses (0-0.1 mg/kg/injection), or increasing food amounts combined with a fixed drug dose (0-0.1 mg/kg/injection). Three alpha 1 sparing compounds with various levels of functional selectivity at alpha 2, alpha 3, and alpha 5 subunit-containing GABA A receptors (a2GABA A , a3GABA A , a5GABA A , respectively) were evaluated. The compounds YT-III-31 (0-0.1 mg/kg/injection), MP-III-24 (0-0.1 mg/kg/injection), and MP-III-80 (0-0.1 mg/kg/injection), with functional selectivity for a3GABA A , a2/3GABA A , and a2/3/5GABA A receptors, respectively, were not self-administered on their own, and failed to reliably produce enhancement of food choice. These results suggest that alpha 1 sparing compounds do not function as reinforcers on their own in drug naïve subjects and is similar to outcomes obtained with cocaine-experienced subjects. However, unlike with cocaine experience, alpha 1 sparing compounds did not reliably enhance choice of another reinforcer (i.e., food). These experiments are currently being replicated with a nonselective BZ, midazolam, and the alpha 1 preferring compound, zolpidem, in the same subjects. From a therapeutic perspective, alpha 1 sparing compounds may hold promise as treatments for anxiety with reduced potential for misuse and in the treatment of BZ use disorder. This research is supported by the National Institute on Drug Abuse (NIDA) grants DA054177 and DA045011 to S.L.H, DA011792 to J.K.R., DA039167 to K.B.F., and subawards to J.M.C under NIDA grants R01DA043204 and R01DA054177 and National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant R01AA029023.

Behavioral effects of triazolam and pregnanolone combinations: reinforcing and sedative-motor effects in female rhesus monkeys

Self-administration of progesterone and synthetic neuroactive steroids by male rhesus monkeys

Self-Administration of Benzodiazepines in Drug-Naïve Rhesus Monkeys: Role of GABAA Receptor Subtypes

Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys

Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus Monkeys Responding under a Progressive-Ratio Schedule

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

Activity of the chloro- and triazolo-benzodiazepines. Behavioural studies in the monkey (Macaca mulatta)

Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam

Distinct mechanisms of allopregnanolone and diazepam underlie neuronal oscillations and differential antidepressant effect

Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam

Allosteric Modulation of GABA←A Receptors by Steroids and Related Compounds : Functional and Binding Studies.

Differential effects of allopregnanolone and diazepam on social behavior through modulation of neural oscillation dynamics in basolateral amygdala and medial prefrontal cortex

Allopregnanolone mediates affective switching through modulation of oscillatory states in the basolateral amygdala

Sex differences in diazepam effects and parvalbumin-positive GABA neurons in trait anxiety Long Evans rats

Comparison of anxiolytic effects of allopregnanolone and diazepam on the elevated plus-maze in mice

Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial

Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations

Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice

Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults

Combination Effects of (Tri)Azole Fungicides on Hormone Production and Xenobiotic Metabolism in a Human Placental Cell Line